神力股份(603819.SH):申請撤回2022年度非公開發行A股股票申請文件
格隆匯10月11日丨神力股份(603819.SH)公佈,公司於2022年10月11日召開第四屆董事會第八次會議和第四屆監事會第八次會議,審議通過了《關於申請撤回公司2022年度非公開發行A股股票申請文件的議案》,同意公司向中國證券監督管理委員會申請撤回此次非公開發行A股股票申請文件。
綜合考慮資本市場環境變化,並結合公司發展戰略,經審慎分析並與中介機構等相關各方充分溝通,公司決定向中國證監會申請撤回2022年度非公開發行A股股票的申請文件並在對2022年度非公開發行A股股票預案作出適當調整後適時重新申報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.